Everyone ... Urgent action needed to put the 101 i
Post# of 82672
Thank you gmili !!! All of us need to let Senator Coons, Senator Tillis and Director Iancu that we support their efforts with regards the 101. In addition, we also need to let Senator's Coon and Tillis that we support there efforts in the bipartisan bill on the 101 to end it's misuse. All members of the Supreme Court, Director Iancu of the PTAB and a numberous Senators all agree that something needs to be done. Lets write them and let them know that we agree. Lets get our family, friends and work mates to all write and call them as soon as possible. Make a difference!
Email, Twitter and Call the following:
Chairman
Thom Tillis (R-NC) https://www.tillis.senate.gov/public/
Twitter: https://twitter.com/SenThomTillis?ref_src=tws...Fpublic%2F
Born on August 30, 1960 into a working-class family, Senator Thom Tillis became a top-level executive at PricewaterhouseCoopers and IBM by the age of 36. After a 22-year private sector career, Tillis was elected to the North Carolina House of Representatives in 2006 and was selected by his peers to serve as Speaker of the House from 2011 to 2014. As Speaker, Tillis played an instrumental role in reforming North Carolina’s tax and regulatory codes. Tillis was elected to the Senate in 2014, narrowly defeating Democrat incumbent Kay Hagan, winning by approximately 50,000 votes (or 1.7% margin). Tillis currently serves on five Senate Committees: the Committee on Armed Services; the Committee on Banking, Housing, and Urban Affairs; the Committee on the Judiciary; the Committee on Veterans’ Affairs; and the Special Committee on Aging.
Tillis has been active on IP issues in recent years. With respect to patents, during the markup of the PATENT Act, Senator Tillis submitted two amendments. The first would extend the sunset date on Covered Business Method (CBM) review. Currently, as a result of the AIA, CBM will sunset 8 years after it became effective, which would be September 16, 2020. Under the Tillis Amendment, CBM would not sunset for an additional 8 years, or until September 16, 2028. The biotechnology and pharmaceutical industries were undoubtedly extremely pleased with his second proposed Amendment, which would make it impossible for an IPR to be filed against pharmaceutical patents or patents that cover biological products that have been approved by the FDA. In October 2015, Tillis co-sponsored the Defend Trade Secrets Act of 2015, which was signed into law in 2016.
In a statement announcing the Senate IP Subcommittee in January 2019, Tillis said:
“In recent years our country has been faced with a number of challenges in our intellectual property system, from rampant theft from state actors like China, to confusion among innovators and inventors about what is even patentable. These issues are causing our nation’s economy to lose billions of dollars annually and threaten our country’s long-term technological dominance.”
Ranking Member https://www.coons.senate.gov/
Senator Chris Coons (D-DE) Twitter: https://twitter.com/ChrisCoons?ref_src=twsrc%...r%5Eauthor
Christopher A. Coons (D-DE) https://www.coons.senate.gov/
Senator Chris Coons (D-DE) represents Delaware in the United States Senate. He was elected in 2010 and reelected to a full six-year term in 2014.
A scientist by training who received a B.A. in Chemistry from Amherst College prior to attending Yale Law School, Coons spent eight years working in the private sector for an advanced materials manufacturing company in Delaware prior to being elected to the Senate. Thus, Coons knows firsthand how important intellectual property protections are to promoting investments in breakthrough technologies and cures.
On the Senate Judiciary Committee, he has fought to strengthen and modernize the nation’s patent system and establish new protections for American inventions and innovations. Senator Coons’ intellectual property priorities include providing a federal forum for victims of trade secret theft; modernizing U.S. patent law via the Support Technology and Research for Our Nation’s Growth (STRONG) Patents Act, which he first introduced in 2015; protecting U.S. consumers from counterfeit goods; and promoting global protection of IP rights. Among the focuses of the STRONG Patents Act are eliminating fee diversion from the USPTO and “ensuring balance” in post-grant proceedings.
Senator Coons has remarked that “it is important for us to look hard at the ways in which the patent system has been mischaracterized, and how those who rely on it to defend their inventions and innovations have been mischaracterized in the debate and discussions of the last few years.” A Senator who is so in tune with the issues facing inventors and patents is rare, and his leadership on the Senate’s IP Subcommittee signals potential for real change in the near future.
Read More: https://investorshangout.com/post/view?id=536...z5hJOnJVR9
Support Director Iancu
Eligibility2019@uspto.gov
OCCOfeedback@uspto.gov
A Plea for All IP Stakeholders: Support Director Iancu’s Efforts to Restore the Value of U.S. Patents
https://www.ipwatchdog.com/2019/03/05/a-plea-...id=106976/
USPTO Director Andrei Iancu’s 2019 Revised Patent Subject Matter Eligibility Guidance promises to virtually eliminate the greatest patent problem of our time. If implemented properly by the examiners and Patent Trial and Appeal Board (PTAB) judges, the guidance could solve the 101 mayhem and the incredible harm that it has done to inventors of computer implemented inventions. The guidance will also increase the value of patents, since strategic infringers will not be able to use the PTAB as the killing ground for patents using subject matter eligibility.
Director Iancu needs us to support him with positive public comments as justification for his guidance and, very importantly, to suggest improvements to his guidance for its final/future version(s) and its implementation.
Please send the following text with any of your edits to Eligibility2019@uspto.gov by the March 8, 2019 deadline.
Director Iancu:
I would like to thank you for your initiative to resolve the 101 mayhem. Your subject matter eligibility guidance will help with most of the 101 problems if interpreted and implemented properly by the examiners and PTAB judges. Therefore, the highest risk to your subject matter eligibility guidance is the interpretation and implementation by the examiners and PTAB judges. The following are suggestions on how to further improve the guidance and how to ensure its correct interpretation and implementation.
Zerify Inc (ZRFY) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.